LEDERMAN SETH

PrivateCIK: 1563420
Location

NEW YORK, NY

LEDERMAN SETH (Chief Executive Officer) purchased 14.1% of their position (16.73K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market

Open‑market purchase worth $22.1K — a moderate purchase. The strongest form of insider conviction signal.

P · 1 purchase
InsiderLEDERMAN SETHCIK 1563420
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+16.73K
Net shares
Net buyer
$22.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
16.73K acquired
Non-Derivative Transactions1

Common Stock, $0.001 par value

Indirect
P · Purchase

Shares

+16.73K

Price / share

$1.32

Trade value

$22.09K

% of position

14.1%
3/24/2021
118.27K135K
Total

Net shares

+16.73K

Net value

$22.09K

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)8

Common Stock, $0.001 par value

Indirect
Shares owned31.00

Common Stock, $0.001 par value

Indirect
Shares owned33.00

Common Stock, $0.001 par value

Indirect
Shares owned59.00

Common Stock, $0.001 par value

Indirect
Shares owned459.00

Common Stock, $0.001 par value

Indirect
Shares owned30.00

Common Stock, $0.001 par value

Direct
Shares owned177.00

Common Stock, $0.001 par value

Indirect
Shares owned30.00

Common Stock, $0.001 par value

Indirect
Shares owned205.00
Total
177.00 direct·847.00 indirect1.02K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
LEDERMAN SETH — Insider Transaction (Form 4) Filed Mar 25, 2021 | Finecho